The Food and Drug Administration (FDA) has approved Netspot (Advanced Accelerator Applications), a radioactive diagnostic agent for positron emission topography (PET) imaging. The probe will aid in ...
BERLIN and YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- On June 30, 2021, Health Canada approved Eckert & Ziegler Radiopharma's GalliaPharm® Ge68/Ga-68 generator for use with Advance Accelerator ...
The FDA has approved a novel PET imaging diagnostic agent for neuroendocrine tumors from Advanced Accelerator Applications ($AAAP). The nod comes 7 months after the ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the diagnostic imaging agent Netspot to detect rare neuroendocrine tumors. Netspot (Advanced ...
Advanced Accelerator Application SA (NASDAQ:AAAP) has inked a NETSPOT distribution deal with Cardinal Health Inc (NYSE:CAH), bringing to two the number of partners tapped to supply the patented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback